who qualifies for semaglutide GLP-1 for Weight Loss? Who Qualifies for Ozempic for

seizures and hearing damage are the most serious side effects

As you lose weight on tirzepatide, your levothyroxine dose may need reduction

FDA-Approved Tirzepatide: What Consumers Should Understand The distinction between compounded and FDA-approved tirzepatide products is especially important in 2026 given the regulatory changes affecting compounded GLP-1 medications

In some studies , average weight loss has been around 15% with semaglutide 2.4 mg over about 68 weeks, and roughly 15% to 21% with tirzepatide over about 72 weeks depending on dose

Her internal medicine background enables her to safely coordinate weight loss treatment with existing medications and medical conditions